124 related articles for article (PubMed ID: 15046050)
21. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene.
Cavaco BM; Guerra L; Bradley KJ; Carvalho D; Harding B; Oliveira A; Santos MA; Sobrinho LG; Thakker RV; Leite V
J Clin Endocrinol Metab; 2004 Apr; 89(4):1747-52. PubMed ID: 15070940
[TBL] [Abstract][Full Text] [Related]
22. A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome.
Moon SD; Park JH; Kim EM; Kim JH; Han JH; Yoo SJ; Yoon KH; Kang MI; Lee KW; Son HY; Kang SK; Oh SJ; Kim KM; Yoon SJ; Park JG; Kim IJ; Kang HC; Hong SW; Kim KR; Cha BY
J Clin Endocrinol Metab; 2005 Feb; 90(2):878-83. PubMed ID: 15613436
[TBL] [Abstract][Full Text] [Related]
23. Re: Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
Guarnieri V; Bisceglia M; Bonfitto N; Cetani F; Marcocci C; Minisola S; Battista C; Chiodini I; Cole DE; Scillitani A
Surgery; 2008 Nov; 144(5):839-40. PubMed ID: 19081034
[No Abstract] [Full Text] [Related]
24. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing.
Koikawa K; Okada Y; Mori H; Kawaguchi M; Uchino S; Tanaka Y
Intern Med; 2018 Mar; 57(6):841-844. PubMed ID: 29225260
[TBL] [Abstract][Full Text] [Related]
25. Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2.
Hobbs MR; Rosen IB; Jackson CE
Am J Hum Genet; 2002 May; 70(5):1376-7. PubMed ID: 11951180
[No Abstract] [Full Text] [Related]
26. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.
Carpten JD; Robbins CM; Villablanca A; Forsberg L; Presciuttini S; Bailey-Wilson J; Simonds WF; Gillanders EM; Kennedy AM; Chen JD; Agarwal SK; Sood R; Jones MP; Moses TY; Haven C; Petillo D; Leotlela PD; Harding B; Cameron D; Pannett AA; Höög A; Heath H; James-Newton LA; Robinson B; Zarbo RJ; Cavaco BM; Wassif W; Perrier ND; Rosen IB; Kristoffersson U; Turnpenny PD; Farnebo LO; Besser GM; Jackson CE; Morreau H; Trent JM; Thakker RV; Marx SJ; Teh BT; Larsson C; Hobbs MR
Nat Genet; 2002 Dec; 32(4):676-80. PubMed ID: 12434154
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid carcinoma.
Mittendorf EA; McHenry CR
J Surg Oncol; 2005 Mar; 89(3):136-42. PubMed ID: 15719375
[TBL] [Abstract][Full Text] [Related]
28. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
29. Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome.
Panicker LM; Zhang JH; Dagur PK; Gastinger MJ; Simonds WF
Endocr Relat Cancer; 2010 Jun; 17(2):513-24. PubMed ID: 20304979
[TBL] [Abstract][Full Text] [Related]
30. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
31. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation.
Aldred MJ; Talacko AA; Savarirayan R; Murdolo V; Mills AE; Radden BG; Alimov A; Villablanca A; Larsson C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):212-8. PubMed ID: 16448924
[TBL] [Abstract][Full Text] [Related]
32. A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone.
Yamashita Y; Akiyama T; Mizusawa N; Yoshimoto K; Goto M
Int J Oral Maxillofac Surg; 2007 Apr; 36(4):365-9. PubMed ID: 17052894
[TBL] [Abstract][Full Text] [Related]
33. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
Sarquis MS; Silveira LG; Pimenta FJ; Dias EP; Teh BT; Friedman E; Gomez RS; Tavares GC; Eng C; De Marco L
Surgery; 2008 May; 143(5):630-40. PubMed ID: 18436011
[TBL] [Abstract][Full Text] [Related]
34. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
[TBL] [Abstract][Full Text] [Related]
35. Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome.
Bradley KJ; Hobbs MR; Buley ID; Carpten JD; Cavaco BM; Fares JE; Laidler P; Manek S; Robbins CM; Salti IS; Thompson NW; Jackson CE; Thakker RV
J Intern Med; 2005 Jan; 257(1):18-26. PubMed ID: 15606373
[TBL] [Abstract][Full Text] [Related]
36. Assessing the contribution of HRPT2 to the pathogenesis of jaw fibrous dysplasia, ossifying fibroma, and osteosarcoma.
de Mesquita Netto AC; Gomez RS; Diniz MG; Fonseca-Silva T; Campos K; De Marco L; Carlos R; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):359-67. PubMed ID: 23453027
[TBL] [Abstract][Full Text] [Related]
37. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome.
Jackson CE; Norum RA; Boyd SB; Talpos GB; Wilson SD; Taggart RT; Mallette LE
Surgery; 1990 Dec; 108(6):1006-12; discussion 1012-3. PubMed ID: 2123361
[TBL] [Abstract][Full Text] [Related]
38. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism.
Iacobone M; Barzon L; Porzionato A; Masi G; Macchi V; Marino F; Viel G; Favia G
Surgery; 2007 Dec; 142(6):984-91; discussion 984-91. PubMed ID: 18063086
[TBL] [Abstract][Full Text] [Related]
39. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.
Korpi-Hyövälti E; Cranston T; Ryhänen E; Arola J; Aittomäki K; Sane T; Thakker RV; Schalin-Jäntti C
J Clin Endocrinol Metab; 2014 Sep; 99(9):3044-8. PubMed ID: 24823466
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic Mitochondrial DNA Mutation Load Inversely Correlates with Malignant Features in Familial Oncocytic Parathyroid Tumors Associated with Hyperparathyroidism-Jaw Tumor Syndrome.
De Luise M; Iommarini L; Marchio L; Tedesco G; Coadă CA; Repaci A; Turchetti D; Tardio ML; Salfi N; Pagotto U; Kurelac I; Porcelli AM; Gasparre G
Cells; 2021 Oct; 10(11):. PubMed ID: 34831144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
